Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Approval Study of MelaFind

NCT01700114 is registered in ClinicalTrials.gov with MELA Sciences, Inc. as lead sponsor.

NCT NCT01700114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01700114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Approval Study of MelaFind
Lead sponsor
MELA Sciences, Inc.
Phase
Observational
Overall status
Terminated
Start date
November 30, 2012
Completion date
January 31, 2016
Enrollment
487 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma